Across its top 20 institutional holders, MART's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 8/100, avg. turnover score 24/100).

Quarterly Activity

Recent Activity

+$13.0M

Total Buy Value

$9.6M

Total Sell Value

New buy2

Trim8

Add10

Sold out1

Net Buyers

Net Sellers

Smart Money Convergence

MART does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

00888H810

FAQ

Who are the top institutional investors holding ALLIANZIM US EQ BFFR10 MR-US (MART)?

Major stakeholders currently include Cambridge Investment Research Advisors, Inc. ($5.0M), Commonwealth Equity Services, LLC ($2.6M), Osaic Holdings, INC. ($2.5M). Based on the latest 13F filings, there are a total of 23 tracked investment funds and institutions maintaining positions in MART.

What is the overall institutional sentiment toward MART recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.6M, driven by 12 managers accumulating shares while 9 reduced their exposure.

Which institutions have been selling or reducing their MART positions?

In the latest period, 8 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $9.6M.

Are there any notable investors adding MART to their portfolios?

Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 10 existing holders added to their shares. The total reported buy value for the quarter amounted to $13.0M.